Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Berlin, Christopher [VerfasserIn]   i
 Cottard, Félicie [VerfasserIn]   i
 Willmann, Dominica [VerfasserIn]   i
 Urban, Sylvia [VerfasserIn]   i
 Tirier, Stephan Marius [VerfasserIn]   i
 Marx, Lisa [VerfasserIn]   i
 Rippe, Karsten [VerfasserIn]   i
 Schmitt, Mark [VerfasserIn]   i
 Petrocelli, Valentina [VerfasserIn]   i
 Greten, Florian R. [VerfasserIn]   i
 Fichtner-Feigl, Stefan [VerfasserIn]   i
 Kesselring, Rebecca [VerfasserIn]   i
 Metzger, Eric [VerfasserIn]   i
 Schüle, Roland [VerfasserIn]   i
Titel:KMT9 controls sternness and growth of colorectal cancer
Verf.angabe:Christopher Berlin, Félicie Cottard, Dominica Willmann, Sylvia Urban, Stephan M. Tirier, Lisa Marx, Karsten Rippe, Mark Schmitt, Valentina Petrocelli, Florian R. Greten, Stefan Fichtner-Feigl, Rebecca Kesselring, Eric Metzger, and Roland Schüle
Jahr:2022
Umfang:11 S.
Fussnoten:Published Online First: November 4, 2021 ; Gesehen am 11.02.2022
Titel Quelle:Enthalten in: Cancer research
Ort Quelle:Philadelphia, Pa. : AACR, 1916
Jahr Quelle:2022
Band/Heft Quelle:82(2022), 2, Seite 210-220
ISSN Quelle:1538-7445
Abstract:Colorectal cancer is among the leading causes of cancer-associated deaths worldwide. Treatment failure and tumor recurrence due to survival of therapy-resistant cancer stem/initiating cells represent major dinical issues to overcome. In this study, we identified lysine methyltransferase 9 (KMT9), an obligate heterodimer composed of KMT9 alpha and KMT9 beta that monomethylates histone H4 at lysine 12 (H4K12mel), as an important regulator in colorectal tumorigenesis. KMT9 alpha and KMT9 beta were overexpressed in colorectal cancer and colocalized with H4K12me1 at promoters of target genes involved in the regulation of proliferation. Ablation of KMT9 alpha drastically reduced colorectal tumorigenesis in mice and prevented the growth of murine as well as human patient-derived tumor organoids. Moreover, loss of KMT9 alpha impaired the maintenance and function of colorectal cancer stem/initiating cells and induced apoptosis specifically in this cellular compartment. Together, these data suggest that KMT9 is an important regulator of colorectal carcinogenesis, identifying KMT9 as a promising therapeutic target for the treatment of colorectal cancer. Significance: The H4K12 methyltransferase KMT9 regulates tumor cell proliferation and sternness in colorectal cancer, indicating that targeting KMT9 could be a useful approach for preventing and treating this disease.
DOI:doi:10.1158/0008-5472.CAN-21-1261
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.1158/0008-5472.CAN-21-1261
 Volltext: https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DOISource&SrcApp=WOS&KeyAID=10.1158%2F0008-54 ...
 DOI: https://doi.org/10.1158/0008-5472.CAN-21-1261
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:colon-cancer
 consensus molecular subtypes
 expansion
 expression
 histone methylation
 model
 recombination
 stem-cells
 tumor-growth
 wnt target genes
K10plus-PPN:1789429714
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68877134   QR-Code
zum Seitenanfang